bioRxiv / medRxivopen access
Engineering nanoparticle surface chemistry for antigen-presenting cell targeting improves specificity and safety of TLR3 agonist cancer immunotherapy
bioengineering
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 398110
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.